Published in:
01-08-2015 | Case report
Alogliptin/sitagliptin
Increased serum pancreatic exocrine enzyme levels: 11 case reports
Published in: Reactions Weekly | Issue 1/2015
Login to get accessExcerpt
Six men with type 2 diabetes mellitus aged between 55 and 72 years, who had received sitagliptin 50 mg/day for 24 weeks, and five women with type 2 diabetes mellitus aged between 60 and 78 years, who had received alogliptin 25 mg/day for 24 weeks, developed increased serum pancreatic exocrine enzyme levels [routes of administration and patient outcomes not stated; durations of treatments to reaction onsets not clearly stated]; patients were part of a study. [See|
Patient characteristics
|
|||
|---|---|---|---|
|
Patient/age (years)/sex
|
DPP-4 inhibitor
|
Alcohol drinking/smoking
|
Pancreatic disease/cholelithiasis
|
|
1/55/M
|
Sitagliptin
|
Yes/No
|
No/Yes
|
|
2/63/M
|
Sitagliptin
|
Yes/No
|
No/No
|
|
3/67/M
|
Sitagliptin
|
No/Yes
|
No/No
|
|
4/62/M
|
Sitagliptin
|
No/Yes
|
No/No
|
|
5/72/M
|
Sitagliptin
|
Yes/Yes
|
No/No
|
|
6/56/M
|
Sitagliptin
|
No/No
|
No/No
|
|
7/68/F
|
Aloglitptin
|
No/No
|
No/No
|
|
8/60/F
|
Alogliptin
|
No/No
|
No/Yes
|
|
9/72/F
|
Alogliptin
|
No/No
|
Yes/No
|
|
10/78/F
|
Alogliptin
|
No/No
|
No/No
|
|
11/67/F
|
Alogliptin
|
No/No
|
No/No
|